PPARG and ulcerative colitis: Pedersen and Brynskov showed that rosiglitazone (a kind of TZDs) enemas could improve impaired PPARγ activity in inflamed colonic epithelium and have beneficial clinical effect in patients with active ulcerative colitis [13].